Christian Brühlmann
Corporate Officer/Principal bij ONCONETIX, INC.
Vermogen: 48 622 $ op 31-05-2024
Actieve functies van Christian Brühlmann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ONCONETIX, INC. | Corporate Officer/Principal | 01-12-2023 | - |
ProteoMediX AG
 ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Oprichter | 01-01-2010 | - |
| Corporate Officer/Principal | 01-11-2018 | - | |
| Directeur/Bestuurslid | 01-01-2010 | 01-11-2018 | |
| Operationeel Directeur | 01-01-2010 | 01-11-2018 | |
| Financieel Directeur/CFO | 01-01-2010 | 01-11-2018 |
Loopbaan van Christian Brühlmann
Opleiding van Christian Brühlmann
| University of Zurich | Masters Business Admin |
Statistieken
Internationaal
| Zwitserland | 3 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
- Beurs
- Insiders
- Christian Brühlmann
- Ervaring
